News and Trends 26 Sep 2022
Kupando raises €13M in series A funding round led by Remiges Ventures
A company developing agonists that stimulate immune cells today (September 26) announced it has secured €13 million ($12.6 million) in series A funding. Germany-based Kupando develops TLR/47 that stimulate innate…